Royalty Pharma published press releases by date and/or category

Royalty Pharma Announces Charitable Alliance with Mount Sinai

Establishes Mount Sinai-Royalty Pharma Alliance for Health Equity Research in collaboration with the Institute for Health Equity Research Alliance will support innovative, sustainable initiatives and policies that address systemic inequities in health care NEW YORK, NY, May 16, 2022 - Royalty

Royalty Pharma Reports First Quarter 2022 Results

NEW YORK , NY,  May 05, 2022 - Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the first quarter of 2022 and reaffirmed full-year 2022 guidance for Adjusted Cash Receipts(1) (a non-GAAP financial measure).

Royalty Pharma Declares Second Quarter 2022 Dividend

NEW YORK, NY, April 18, 2022 – The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2022 of $0.19 per Class A ordinary share. The dividend will be paid on June 15, 2022, to shareholders of record at the close of business on May

Royalty Pharma Announces Inaugural Investor Day

NEW YORK, NY, February 16, 2022 Royalty Pharma plc (Nasdaq: RPRX) today announced that it will host an inaugural Investor Day in New York City on Tuesday, May 17, 2022, starting at 8:30 a.m. ET. Royalty Pharma senior executives will present on the outlook for royalty funding in life sciences

Stay up to date

Subscribe to Royalty Pharma news and alerts